Pfizer Combating Patent Loss with New Drug
April 3, 2009 by Alex
Filed under New Patents
Pfizer knows that the days are numbered for its $1.2 billion drug, Detrol. With Detrol’s main patent set to expire in September 2012, and patents on Detrol LA due to end between 2012 and 2020, Pfizer is looking to launch a new drug to replace the forthcoming loss of revenue.
As reported by Crain’s New York Business, Detrol is used to fight over-active bladder. Pfizer’s new drug, Toviaz, is structurally similar to Detrol, but it has two doses instead of one. Pfizer officials hope this characteristic will give physicians and patients more flexibility in treatment for the drug’s efficacy and tolerability.
The extended-release formulation of Detrol, called Detrol LA, is currently the market leader, with a 49% share. But Pfizer is hoping Toviaz can take its place, and the company is actually introducing a printed support plan called “YourWay.” This plan will be handed out to patients with sample packs of the drug tucked inside. Pfizer is hoping that this idea will drum up awareness for the condition in 10 markets, including Boston and Atlanta.
We’ll see if it works.
Pfizer Combating Patent Loss with New Drug DynamicPatents | Weak Bladder on Sun, 7th Jun 2009 5:22 pm
[...] Pfizer Combating Patent Loss with New Drug DynamicPatents Posted by root 5 hours ago (http://www.dynamicpatents.com) Apr 3 2009 tags detrol detrol la market share over active bladder and oh if you want a pic to show with your comment go get a gravatar posting tweet powered by twitter tools log in middot wordpress middot xhtml Discuss | Bury | News | Pfizer Combating Patent Loss with New Drug DynamicPatents [...]